Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-17

Clinical Trial Update: Exparel Use in Bilateral TAP Blocks for Postoperative Pain Control [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Exparel (bupivacaine liposome injectable suspension) use in bilateral TAP blocks for postoperative pain control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: St. Luke's Hospital, Pennsylvania | Conditions: Postoperative Pain, Surgery | Phase 4 | Status: COMPLETED